10.13.17
CPhI Worldwide, along with co-located events ICSE, InnoPack, P-MEC and FDF, will take place October 24-26, 2017 in Messe Frankfurt, Germany. Together the events feature more than 2,500 exhibits and brings in 42,000 attendees from 150 countries.
CPhI is dedicated to pharmaceutical ingredients; ICSE is for outsourcing solution providers, contract manufacturing and services; InnoPack is for pharmaceutical packaging and drug delivery systems; P-MEC is for pharmaceutical machinery, technology and equipment; and Finished Dosage Formulation (FDF) covers all aspects of the finished dosage supply chain.
The meeting features global pavilions and educational sessions offering insight on key strategic and operational issues affecting drug development, delivery and commercialization. Attendees will have access to more than 150 industry seminars covering the pharmaceutical market continuum, along with the opportunity to establish new business relationships, meet with global partners, and keep abreast of the latest industry trends. Topics include everything from bioavailability to serialization, and scaling up API to managing the supply chain, see session highlights below.
The exhibition is organized into dedicated zones covering: Custom Manufacturing & API Fine Chemicals & Intermediates, API, North American Zone, Excipients, Finished Dosage Formulation, Finished Dosage Formulation & API, CPhI - Integrated Pharma.
CPhI is co-located with the ICSE expo, which features outsourcing service providers, contract manufacturing and services, covers the latest pharmaceutical industry trends across key sectors.
The ICSE expo features nearly 300 outsourcing service providers for the pharmaceutical industry, a forum for business development, networking, and educational sessions including the latest strategies in pharmaceutical development, manufacturing, and partnerships with leading industry experts.
ICSE represents all sectors of the pharma/biopharma industry, serving the contract services sector with outsourcing service providers, including clinical trials, contract research, contract manufacturing, biopharma services, IT, analytical services, packaging services and logistics. ICSE comprises six zones: Logistics & Cold Chain Zone; BioServices and Analytical Lab Services Zones. (Pre) Clinical Trials Zone; New Exhibitor Zone; and North America Zone.
Session Highlights
Serialization – the vital role of the CDMO, presented by Rick Seibert, Sharp: CPO perspective; Jean-Maire Aulnette, Tracelink: EPCIS provider perspective; Bjoern Rosner, Biogen: Pharma perspective, October 24, 11:10 a.m. - 11:40 a.m., G1A1
Model-based technology selection for bioavailability enhancement, presented by David Lyon, Director Research, Capsugel, October 24, 1:10 p.m. - 1:40 p.m., G1A1
Development manufacture of HPAPI drug products throughout the clinical phases, presented by David O' Connell, Director of Scientific Affairs, PCI Pharma Services, October 24, 2:30 p.m. - 3:00 p.m., G1A1
Centralizing stability studies – managing risks, presented by Karan Bagaria, Business Development Director, Recipharm, October 24, 4:30 p.m. - 5:00 p.m., G1A1
Quality by design and expertise: accelerating time to market of complex oral solid dosage forms, presented by Lucile Kowalski, Project Manager, Skyepharma; Guy Vergnault, VP Research & Development, Skyepharma, October 25, 10:30 a.m. - 11:00 a.m., G1A1
A pragmatic (USP) approach to extractables & leachables evaluation for Single Use systems, presented by Andreas Nixdorf, Business Development Manager Extractables & Leachables Testing, SGS, October 25, 11:10 a.m. - 11:40 a.m., G1A1
Enterprise serialization - lessons learned: from concept to execution
Justin Schroeder, Senior Executive Director of Global Marketing and Design, PCI pharma services, October 25, 11:50 a.m. - 12:20 p.m., G1A1
Contract manufacturing services for pre-filled syringes – from standard solutions to complex products, presented by Stefan Czvitkovich, Director PP Sterile Pharmaceuticals Central Europe, Fresenius Kabi, October 25, 3:10 p.m. - 3:40 p.m., G1A1
Time to scale up your API? Optimizing your process can yield huge savings, presented by Evan Boswell, Principal Scientist, Pfizer CentreOne Contract Manufacturing, October 25, 3:50 p.m. - 4:20 p.m., G1A1
A CDMO’s Perspective: Our Role in Today’s Supply Chain, presented by Matt Frizzle, Director, Business Development, CMO, BioVectra Inc.; Dr. Marc Sauer, Vice President, Research & Development, BioVectra Inc., October 26, 1:10 p.m. - 1:40 p.m., G1A1
Exhibition Schedule
Tuesday, October 24: 9:30 a.m. - 5:30 p.m.
Wednesday, October 25: 9:30 a.m. - 5:30 p.m.
Thursday, October 26: 9:30 a.m. - 4:00 p.m.
CPhI is dedicated to pharmaceutical ingredients; ICSE is for outsourcing solution providers, contract manufacturing and services; InnoPack is for pharmaceutical packaging and drug delivery systems; P-MEC is for pharmaceutical machinery, technology and equipment; and Finished Dosage Formulation (FDF) covers all aspects of the finished dosage supply chain.
The meeting features global pavilions and educational sessions offering insight on key strategic and operational issues affecting drug development, delivery and commercialization. Attendees will have access to more than 150 industry seminars covering the pharmaceutical market continuum, along with the opportunity to establish new business relationships, meet with global partners, and keep abreast of the latest industry trends. Topics include everything from bioavailability to serialization, and scaling up API to managing the supply chain, see session highlights below.
The exhibition is organized into dedicated zones covering: Custom Manufacturing & API Fine Chemicals & Intermediates, API, North American Zone, Excipients, Finished Dosage Formulation, Finished Dosage Formulation & API, CPhI - Integrated Pharma.
CPhI is co-located with the ICSE expo, which features outsourcing service providers, contract manufacturing and services, covers the latest pharmaceutical industry trends across key sectors.
The ICSE expo features nearly 300 outsourcing service providers for the pharmaceutical industry, a forum for business development, networking, and educational sessions including the latest strategies in pharmaceutical development, manufacturing, and partnerships with leading industry experts.
ICSE represents all sectors of the pharma/biopharma industry, serving the contract services sector with outsourcing service providers, including clinical trials, contract research, contract manufacturing, biopharma services, IT, analytical services, packaging services and logistics. ICSE comprises six zones: Logistics & Cold Chain Zone; BioServices and Analytical Lab Services Zones. (Pre) Clinical Trials Zone; New Exhibitor Zone; and North America Zone.
Session Highlights
Serialization – the vital role of the CDMO, presented by Rick Seibert, Sharp: CPO perspective; Jean-Maire Aulnette, Tracelink: EPCIS provider perspective; Bjoern Rosner, Biogen: Pharma perspective, October 24, 11:10 a.m. - 11:40 a.m., G1A1
Model-based technology selection for bioavailability enhancement, presented by David Lyon, Director Research, Capsugel, October 24, 1:10 p.m. - 1:40 p.m., G1A1
Development manufacture of HPAPI drug products throughout the clinical phases, presented by David O' Connell, Director of Scientific Affairs, PCI Pharma Services, October 24, 2:30 p.m. - 3:00 p.m., G1A1
Centralizing stability studies – managing risks, presented by Karan Bagaria, Business Development Director, Recipharm, October 24, 4:30 p.m. - 5:00 p.m., G1A1
Quality by design and expertise: accelerating time to market of complex oral solid dosage forms, presented by Lucile Kowalski, Project Manager, Skyepharma; Guy Vergnault, VP Research & Development, Skyepharma, October 25, 10:30 a.m. - 11:00 a.m., G1A1
A pragmatic (USP) approach to extractables & leachables evaluation for Single Use systems, presented by Andreas Nixdorf, Business Development Manager Extractables & Leachables Testing, SGS, October 25, 11:10 a.m. - 11:40 a.m., G1A1
Enterprise serialization - lessons learned: from concept to execution
Justin Schroeder, Senior Executive Director of Global Marketing and Design, PCI pharma services, October 25, 11:50 a.m. - 12:20 p.m., G1A1
Contract manufacturing services for pre-filled syringes – from standard solutions to complex products, presented by Stefan Czvitkovich, Director PP Sterile Pharmaceuticals Central Europe, Fresenius Kabi, October 25, 3:10 p.m. - 3:40 p.m., G1A1
Time to scale up your API? Optimizing your process can yield huge savings, presented by Evan Boswell, Principal Scientist, Pfizer CentreOne Contract Manufacturing, October 25, 3:50 p.m. - 4:20 p.m., G1A1
A CDMO’s Perspective: Our Role in Today’s Supply Chain, presented by Matt Frizzle, Director, Business Development, CMO, BioVectra Inc.; Dr. Marc Sauer, Vice President, Research & Development, BioVectra Inc., October 26, 1:10 p.m. - 1:40 p.m., G1A1
Exhibition Schedule
Tuesday, October 24: 9:30 a.m. - 5:30 p.m.
Wednesday, October 25: 9:30 a.m. - 5:30 p.m.
Thursday, October 26: 9:30 a.m. - 4:00 p.m.
